SMAIO overview

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today published its 2023 annual results 1 approved by the Board of Directors on April 15, 2024. Philippe ROUSSOULY, Chairman and CEO of SMAIO , said: “The year 2023 marked a major turning point in SMAIO's...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA, eligible for PEA-PME equity savings plans), a French player specialized in complex spine surgery with a comprehensive offer including software, adaptative implants and related services, today published its sales for the first half of 2023 and issued an update on its development. Philippe ROUSSOULY, Chairman and CEO of SMAIO, said: “The first...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player specializing in transforming vertebral fusion with breakthrough innovation, today announced that it has obtained €2.5m in non-dilutive financing. A €1.0m loan from Bpifrance to integrate artificial intelligence into SMAIO's solutions Bpifrance has granted SMAIO a €1.0m Innovation Research and Development (R&D) loan with a...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player specializing in transforming vertebral fusion with breakthrough innovation, today announced that it has received FDA 510(k) clearance for the customized surgery planning software co-developed with NuVasive 1 . Obtaining FDA 510(k) clearance for this customized version of the surgery planning software represents a key milestone in...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player specialized in complex spine surgery with a global offer comprising software, today published its 2022 annual results 1 approved by the Board of Directors on April 11, 2023. Philippe ROUSSOULY, Chairman and CEO of SMAIO, said: “ The year 2022 has allowed SMAIO to consolidate its foundations which should enable it to achieve its...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA, eligible for PEA-PME equity savings plans), a French player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today published its annual sales for the year to December 31, 2022. Philippe ROUSSOULY, Chairman and CEO of SMAIO, said: “ During our first year of listing, SMAIO...

Regulatory News: SMAIO ( S oftware, M achines and A daptative I mplants in O rthopaedics – Euronext Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA) (Paris:ALSMA), a French player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today announces its indicative financial calendar for 2023. Events Dates 2022 full-year revenue Tuesday, January 17, 2023 2022 full-year results Wednesday, April 12, 2023 Annual General Meeting...